nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

01.12.2015 | Original contribution

Minimizing right ventricular pacing in pacemaker patients with intact and compromised atrioventricular conduction

Results from the EVITA Trial

verfasst von: Prof. Dr. A. Bauer, J. Vermeulen, L. Toivonen, J. Voitk, C. Barr, P. Peytchev

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Unnecessary ventricular pacing is associated with increased morbidity and mortality. Over the years different algorithms have been developed to reduce right ventricular pacing.

Objectives

Goal of the present study was to test the efficacy of the ventricular intrinsic preference (VIP) algorithm in patients with atrioventricular intact (AVi) and atrioventricular compromised (AVc) AV-conduction.

Methods

Evaluation of VIP feature in pacemaker patients (EVITA) was a multicenter, prospective, randomized trial (Trials.gov Identifier: NCT00366158). In total, 389 patients were randomized to AVc group: n = 140/132 VIP OFF/VIP On, AVi group: n = 54/63 VIP OFF/VIP ON). One-month post-implantation AV conduction testing (AVc: PR/AR interval > 210 ms) was performed. Follow-up visits occurred 6 and 12 months after DDD-pacemaker implantation.

Results

In AVi and AVc-patients initiation of the VIP feature significantly reduced incidence of ventricular pacing (AVi: 53 ± 38 vs. 9 ± 21 %, p = 0.0001; AVc: 79 ± 31 vs. 28 ± 35 %, p = 0.0001). DDD-pacemaker implantation per se significantly reduced incidence of AF in VIP ON (AVi 27 vs. 0 %, p < 0.0001; AVc 29 vs. 3 %, p < 0.0001) and VIP OFF patients (AVi 43 vs. 4 %, p < 0.0001; AVc 33 vs. 3 %, p < 0.0001), without significant differences between VIP ON and OFF groups (p > 0.05). In the AVc group activation of VIP significantly reduced incidence of adverse events (AE). All-cause mortality was not significantly different in VIP ON (n = 5) and VIP OFF (n = 4, p > 0.05) patients.

Conclusion

AV search hysteresis (VIP) markedly reduces ventricular pacing both in patients with normal AV conduction and in patients with prolonged PR interval or intermittent AV block.

Andersen HR, Nielsen JC, Thomsen PE et al (1997) Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 350:1210–1216CrossRefPubMed

Sweeney MO, Bank AJ, Nsah E et al (2007) Minimizing ventricular pacing to reduce atrial fibrillation in sinus node disease. N Engl J Med 357:1000–1008CrossRefPubMed

Andersen HR, Nielsen JC, Thomsen PEB et al (1998) Atrioventricular conduction during long-term-follow-up of patients with sick sinus syndrome. Circulation 98:1315–1321CrossRefPubMed

Lamas GA, Lee KL, Sweeney MO et al (2002) Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346:1854–1862CrossRefPubMed

Wilkoff BL, Cook JR, Epstein AE et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3123CrossRefPubMed

Nielsen JC, Thomsen PE, Højberg S et al (2011) DANPACE Investigators. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 32(6):686–696CrossRefPubMed

Pürerfellner H, Brandt J, Israel C et al (2008) Comparison of two strategies to reduce ventricular pacing in pacemaker patients. Pacing Clin Electrophysiol 31(2):167–176CrossRefPubMed

Stierle U, Krüger D, Vincent AM et al (1998) An optimized AV delay algorithm for patients with intermittent atrioventricular conduction. Pacing Clin Electrophysiol 21(5):1035–1043CrossRefPubMed

Kolb C, Schmidt R, Dietl JU et al (2011) PREVENT study group. Reduction of right ventricular pacing with advanced atrioventricular search hysteresis: results of the PREVENT study. Pacing Clin Electrophysiol 34:975–983CrossRefPubMed

10.

Gregoratos G, Abrams J, Epstein AE et al (2002) ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106:2145–2161CrossRefPubMed

11.

Miyamoto M, Kimura Y, Hosoda J et al (2012) Does reducing unnecessary right ventricular pacing improve sympathetic activity and innervations of heart in sinus node disease patients? MVP and Safe R Study. Int Heart J 53:353–358CrossRefPubMed

12.

Murakami Y, Tsuboi N, Inden Y et al (2010) Difference in percentage of ventricular pacing between two algorithms for minimizing ventricular pacing: results of the IDEAL RVP (Identify the Best Algorithm for Reducing Unnecessary Right Ventricular Pacing) study. Europace 12:96–102 (25)PubMedCentralCrossRefPubMed

13.

Boston Scientific corporation http://www.bostonscientific.com/en-US/products/pacemakers/altrua-pacemaker.html

14.

Schuchert A, Kolb C, Hümmer A et al (2008) “Automatic AV hysteresis effectively reduces ventricular pacing in patients with sick sinus node and intermittent AV-Block” Europace 8(Suppl. 1):223/1

15.

Israel-CW (2011) Prevention of atrial fibrillation by prevention of ventricular pacing? Europace 13:765–767CrossRefPubMed

16.

Wiggers C (1925) The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol 73:346–378

17.

Prinzen FW (1999) Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 33:1735–1742PubMedCentralCrossRefPubMed

18.

Veasey RA, Arya A, Silberbauer J et al (2011) The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Europace 13:815–820CrossRefPubMed

19.

Thibault B, Simpson C, Gagné CE et al (2009) Impact of AV conduction disorders on SafeR mode performance. Pacing Clin Electrophysiol 32(Suppl 1):S231–S235CrossRefPubMed

20.

Silberbauer J, Veasey RA, Freemantle N et al (2009) The relationship between high-frequency right ventricular pacing and paroxysmal atrial fibrillation burden. Europace 11:1456–1461CrossRefPubMed

21.

McIntosh R, Veasey RA, Hong PSG et al (2008) The relationship between right ventricular pacing and atrial fibrillation burden in patients with paroxysmal atrial fibrilation. J Interv Card Electrophysiol 21:105CrossRef

22.

Milasinovic G, Sperzel J, Smith TW et al (2006) Reduction of RV pacing by continuous optimization of the AV interval. Pacing Clin Electrophysiol 29:406–412CrossRefPubMed

23.

Gillis AM, Purerfellner H, Israel CW et al (2006) Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol 29:697–705CrossRefPubMed

24.

Olshansky B, Day JD, Moore S et al (2007) Is dualchamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation 115:9–16CrossRefPubMed

25.

Sweeney MO, Ellenbogen KA, Casavant D et al (2005) Multicenter, prospective, randomized safety and efficacy study of a new atrial based managed ventricular pacing mode (MVP) in dual chamber ICDs. J Cardiovasc Electrophysiol 16:811–817CrossRefPubMed

26.

Milasinovic G, Tscheliessnigg K, Boehmer A et al (2008) Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population. Europace 10:151–155CrossRefPubMed

27.

Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937CrossRefPubMed

28.

Ishikawa T, Kimura K, Miyazaki N et al (1992) Diastolic mitral regurgitation in patients with first-degree atrioventricular block. Pacing Clin Electrophysiol 15:1927–1931 (26)CrossRefPubMed

29.

Gold MR, Adler S, Fauchier L et al (2009) SAFARI Investigators. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 6(3):295–301CrossRefPubMed

Titel: Minimizing right ventricular pacing in pacemaker patients with intact and compromised atrioventricular conduction
Results from the EVITA Trial
verfasst von: Prof. Dr. A. Bauer
J. Vermeulen
L. Toivonen
J. Voitk
C. Barr
P. Peytchev
Publikationsdatum: 01.12.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 4/2015
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-015-0394-2

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Minimizing right ventricular pacing in pacemaker patients with intact and compromised atrioventricular conduction

Results from the EVITA Trial

Abstract

Introduction

Objectives

Methods

Results

Conclusion

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Sind Frauen die fähigeren Ärzte?

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Update Kardiologie

Springer Medizin

Abstract

Introduction

Objectives

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Jahresbericht 2013 des Deutschen Herzschrittmacher- und Defibrillatorregisters, Teil 2 - Implantierbare Cardioverter-Defibrillatoren

Jahresbericht 2013 des Deutschen Herzschrittmacher- und Defibrillatorregisters, Teil 1 – Herzschrittmacher

Elektrodenextraktion

Breitkomplex-Tachykardie bei einem Patienten mit ischämischer Kardiomyopathie

Komplikationsmanagement in der invasiven Elektrophysiologie

Probleme, Komplikationen und Notfälle bei der Schrittmacherimplantation

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Sind Frauen die fähigeren Ärzte?

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Update Kardiologie